Approval · Notice of Compliance 1063 · 2003
AVAXIM: Notice of Compliance 1063
Issued March 24, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1063
- Date
- March 24, 2003
- Company
- Aventis Pasteur LimitedSwiftwater, Pennsylvania, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing facility
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AVAXIM | Not yet assigned | — |
| AVAXIM PEDIATRIC | Not yet assigned | — |
Medicinal ingredients
- HEPATITIS A VACCINE, INACTIVATED 160 UNIT per 0.5ML
- HEPATITIS A VACCINE, INACTIVATED 80 UNIT per 0.5ML